Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Mylan Pregabalin
Pregabalin 25mg
Capsule
Mylan New Zealand Limited
Mylan Laboratories Limited, Maharashtra State, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Mylan Pregabalin
Pregabalin 50mg
Capsule
Mylan New Zealand Limited
Mylan Laboratories Limited, Maharashtra State, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Mylan Pregabalin
Pregabalin 75mg
Capsule
Mylan New Zealand Limited
Mylan Laboratories Limited, Maharashtra State, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Mylan Pregabalin
Pregabalin 150mg
Capsule
Mylan New Zealand Limited
Mylan Laboratories Limited, Maharashtra State, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Mylan Pregabalin
Pregabalin 225mg
Capsule
Mylan New Zealand Limited
Mylan Laboratories Limited, Maharashtra State, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Mylan Pregabalin
Pregabalin 300mg
Capsule
Mylan New Zealand Limited
Mylan Laboratories Limited, Maharashtra State, India
|
Dated this 5th day of March 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz